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Sulfa drugs are widely used in the prophylaxis and treatment of 
Pneumocystis cnrinii pneumonia. Co-trimoxazole, the first-line agent, 
is a coinbination of  sulfamethoxazole and trimethoprim but functions 
as sulfa monotherapy since P. carinii is apparently insensitive to 
trimethoprim. Dapsone, a sulfone, is a commonly used second-line 
agent. Both sulfamethoxazole and dapsone act by binding to 
dihydropteroate synthase (DHPS) (reviewed i n  references [2, 191) (Fig. 
1 ). 
Sulfa-resistant Pneumocyslis carinii may be an emerging public 
health problem. However, since in vitro cultivation of human-derived 
organisms is not possible, molecular tools for determining resistance 
are needed. Genetic polymorphisms in the P. carinii DHPS were firs! 
reported in 1997 [ I  I ] .  Two of the mutations, at positions 55 and 57, 
appear to be in the enzyme active site (Fig. I ,  based on the E. coli 
structure [ I ] ;  MMDB id: 774 I ; PDB id: 1 AJO). These mutations have 
been associated with sulfa exposure, prophylaxis. break-through, or 
treatment failure [4, 7, 9-1 I ,  13-15, 181. 
Fig I Amino acids in the & coli DHPS homologous to mutated amino 
acids in the P c'aruiii DHPS 
These mutations appear to have occurred recently, and then to 
have spread fairly rapidly. In several studies, the mutations were 
infrequent in patient samples obtained before - 1993, and then became 
more frequent as the sulfa drugs became used more widely i n  
prophylaxis [4, 9,  I D ] .  Also, the prevalence of these mutations varies 
geographically, with higher prevalences at sites with older epidemics 
[ 3 , 7 ,  101. 
How did the mutations evolve? There are two main possibilities. 
The mutations might have arisen only once and then spread as 3 result 
of selection on a population level. Alternatively. mutations could arise 
independently in each treated patient and increase as a result of 
selection within host. Obviously. intermediate scenarios (where the 
mutations arose independently but infrequently) are also possible. 
MATERIALS AND METHODS 
In order to understand how these mutations arose, we asked 
whether DHPS mutations were associated with individual strains of 
human-derived P. carinii. Strains were defined by sequencing the 
Internally Transcribed Spacer (ITS) regions. Human-derived P. carinii 
contain >I5 ITS1 types (A-0 )  and >I4 ITS2 types (a-n). More than 50 
different combinations have been identified [ 5 ,  8, 121. We also 
assessed the phylogenetic relatedness of strains with and without 
DHPS mutations. If strains with the mutation comprise a set of closest 
relatives that would also be consistent with a single origin of 
resistance. However, we did not anticipate that any association would 
be perfect, since ITS and DHPS genes are probably unlinked and there 
could be horizontal genetic transfer. 
We obtained ITS and DHPS genotyping data from 57 patient 
isolates retrospectively and prospectively. These patients were from 
Indiana, Atlanta, San Francisco, Los Angeles, and Seattle and were a 
subset of patients used in previous studies [3, 7, 9-1 I ] .  We then 
selected all 37 isolates with monoclonal infections (only single ITS 
type and DHPS type). 
RESULTS AND DISCUSSION 
Characteristics of 37 monoclonal patient isolates are shown in 
Table 1. There were 22 wild types, 14 double mutants and 1 single 
mutant (position 55).  Mutations were more common in Atlanta and 
the West Coast than Indiana, and more common in samples obtained 
more recently, but these differences were not statistically significant. 
Table I .  Charactenstics of isolates used in this study 
Characleristic No. Muranr (%) 
Sire 
Indiana 17 3 (18) 
Atlanta 15 9 (60) 
SFILAlSeattle 5 3 (60) 
Year 
92-97 14 3 (21) 
98-99 23 12 (52) 
One ITS type, Eg, was common in all 3 sites (Table 2). Three 
The other types, Ea, Eb, and Ne, were found in two of the 3 sites. 
other 6 ITS types were only found in single sites. 
Table 2. Distribution of ITS types by site 
Site Types 
Indiana Eb (31, Ee (61, 
Gn -- 
Atlanta 
The distribution of DHPS mutations among ITS types is shown in 
Figure 2. Mutations are very common in some ITS types (such as Ne), 
but not found in others. 
A phylogenetic hypothesis for ITS types of P. carinii, along with 
the association of DHPS mutations by type is shown in Fig. 3. 
Consensus sequences for ITS1 and ITS2 were combined in the same 
manner as found in the isolates in our study. (Genbank accession 
numbers are: ITS1 Type C: AF013808, E: AF013810, G: AFO13812, I: 
AF013814, M: AF013818, N: AF013819; ITS2 Type a: AF013821. b: 
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AF013822, c: AF013823, e: AF013825, g: AF013827, 0 :  AF013835, t: 
AF013840.) We also included two P. carbiii sequences from Macaca 
mularia [6] as outgroups (ITS1 Type A: AF288827, D: AF288834; 
ITS2 Type d: AF288843, f: AF288846). Sequences were aligned in 
ClustalW [ 171 with gap extension penalties set to 7.5. 
lo 1 n 
Ea Eb Ec Ee Eg El Et Go Ig Ne 
Fig.2. Distribution of mutant DHPS genotypes among ITS types. 
A phylogenetic hypothesis was constructed using parsimony 
analysis as implemented in PAUP*4.0b4a [ 161. With gaps considered 
as a fifth character state, 171 characters were constant and 92 were 
parsimony informative. A search (assessing all possible tree 
topologies) resulted in a single most parsimonious tree 262 steps i n  
length (Fig. 3), which we rooted with the P. carinii sequences from M. 
midmu. Values to the left of the nodes within the tree indicate the 
relative support for that particular clade based on 1000 bootstrap 
resamplings of the sequence data. P. cariii strains with and without 
DHPS mutations appear well mixed in the phylogeny. 
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Fig. 3. Evolutionary relationships between isolates used in  this study ITS 
types in blue contain isolates with DHPS mutations. 
We then asked post-hoc, whether certain groups of ITS types 
contained statistically higher numbers of DHPS mutants than other ITS 
type5 using the Fishers’ exact test (Table 3) Among isolates from 
Indiana, Ee isolates were significantly more likely to be DHPS mutants 
than a11 others Among all isolates, Ne, Eg and Ee isolates were more 
likely to contain DHPS mutants than all others This is not an artifact 
associated with date of acquisition, since Ee and Eg are among the 
oldest of the isolates collected. Thus, our data are consistent with the 
possibility that DHPS mutations arose infrequently but on more than 
one occasion. 
Table 3 .  Uneven distribution of DHPS mutants among ITS types 
ITS ~pvpe DHPS mutam WT P value 
Iridiatia o d y  0.03 
Ee 3 3 
Others 0 I 1  
All .sarr1ples 0.003 
Ne, Egor Ee 16 8 
Others 3 10 
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